Retrospective evaluation of single patient investigational new drug (IND) requests in pediatric oncology

BACKGROUND: Single patient Investigational New Drug (IND) applications are one mechanism through which experimental therapies are accessed for children with cancer. The landscape of use, outcomes, and toxicity from single patient INDs remains unknown in pediatric oncology. METHODS: We performed a re...

Descripción completa

Detalles Bibliográficos
Autores principales: Shulman, David S., Kiwinda, Lulla V., Edwards, Stacey, Clinton, Catherine M., Hunt, Sarah, Greenspan, Lianne, Lawler, Kristen D., Reaman, Gregory, Al‐Sayegh, Hasan, Bona, Kira, O'Neill, Allison F., Shusterman, Suzanne, Janeway, Katherine A., Place, Andrew E., Chi, Susan N., Ma, Clement, DuBois, Steven G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982629/
https://www.ncbi.nlm.nih.gov/pubmed/33751835
http://dx.doi.org/10.1002/cam4.3791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982629/
https://www.ncbi.nlm.nih.gov/pubmed/33751835
http://dx.doi.org/10.1002/cam4.3791

Ejemplares similares